Editas Medicine
EDIT
EDIT
220 hedge funds and large institutions have $481M invested in Editas Medicine in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 76 increasing their positions, 62 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 237 → 220 (-17)
38% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 40
Holders
220
Holding in Top 10
–
Calls
$6.11M
Puts
$3.5M
Top Buyers
| 1 | +$28.5M | |
| 2 | +$4.4M | |
| 3 | +$3.98M | |
| 4 |
Squarepoint
New York
|
+$3.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.89M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$8.02M | |
| 3 | -$6.79M | |
| 4 |
Man Group
London,
United Kingdom
|
-$6.09M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$5.02M |